Blog - Page 1638 of 5724

MondayOct 12, 2020 2:10 pm

Pure Extract Technologies Awarded Standard Processing License by Health Canada, Eyes Expansion Plans

Pure Extract Technologies has been awarded Standard Processing License by Health Canada The license will enable the Company to produce, sell cannabis & hemp products to other Licenced Producers in its purpose-built facility located near Whistler, Canada Canada’s ability to export worldwide coupled with Company’s EU-GMP compliant facility makes Pure Extracts a natural partner for companies involved within international distribution Pure Extract Technologies, a privately held British Columbia-domiciled plant extraction company, announced that it had been awarded a Standard Processing Licence by Health Canada under the Cannabis Act, following an extensive and meticulous five-month application and vetting process (https://ibn.fm/xElDa). Pure Extracts…

MondayOct 12, 2020 1:11 pm

The Movie Studio (MVES) Seeks to Expand Footprint Within Burgeoning Online Streaming Sector

Deloitte published report earlier this year looking into growth trends driving the global TMT industry Study found that consumers have embraced online streaming platforms in 2020, with average customer subscribing to three streaming platforms The Movie Studio has sought to capitalize on sector’s growth through launch of its own streaming platform as well as through purchase of content aggregator, BINGE Networks LLC Deloitte ultimately expects online streaming sector to consolidate, with only handful of platforms taking lion’s share of market As the world progresses through what can only be described as a wildly tumultuous year, it is evident that trends,…

MondayOct 12, 2020 12:36 pm

Pac Roots Cannabis Corp. (CSE: PACR) Employs Specialized Proprietary Cultivation Techniques, Seeks to Deliver on Higher-Quality Product Portfolio

Pac Roots Cannabis Corp. dedicated to supplying higher-quality cannabis product PACR enters into strategic licensing agreement with Phenome One Corp, providing access to 350 meticulously-designed cultivars Company has also employed number of proprietary cultivation techniques to ensure quality of end products, which has contributed to PACR’s stellar industry reputation Since completing its RTO and being listed on the CSE in May of 2020, Pac Roots Cannabis Corp. (CSE: PACR) has established a strong reputation within the field of cannabis and hemp cultivation, leveraging upon the exceptional genetics of its specialized cultivars as well as an innovative proprietary cultivation technique to…

MondayOct 12, 2020 12:30 pm

QualityStocksNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Expands Stake in Changyi, Further Positions to Continually Enhance Smart Solutions

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that it has increased its controlling interest in Changyi (Shanghai) Information Technology Co. Ltd. Changyi is a leading independent software vendor that provides intelligent retail and CRM solutions, through which iClick has further enhanced its data-driven Enterprise Solutions business. “Our clients are continually looking for ways to increase operational and marketing efficiencies as they tackle the challenges of doing business in China and the region,” iClick co-founder and CEO Jian "T.J." Tang said in the news release. “Through expanding our stake…

MondayOct 12, 2020 11:58 am

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Updates Shareholders on Two Key Initiatives

Sugarmade (OTCQB: SGMD), today issued a letter to its shareholders, on behalf of its CEO Jimmy Chan, that provided an update on coming expansion steps in regard to its BudCars delivery service as well as the company’s vertical integration. “Today, I want to highlight two themes that will help to drive our value proposition for shareholders over the intermediate term: geographic expansion for BudCars and our move to vertically integrate through the establishment of cultivation operations. Together, they represent tangible catalysts driving both top and bottom-line growth,” Chan stated in the update. “These are exciting times for Sugarmade. We have…

MondayOct 12, 2020 11:53 am

SRAX Inc. (NASDAQ: SRAX) Moving BIGtoken to Separate Company, Announces Malcolm CasSelle as CEO

SRAX moving BIGtoken to separate publicly-traded company through definitive share exchange with Force Protection Video Equipment Corp BIGtoken compensates over 16 million users for data which marketers access for fee Malcolm CasSelle appointed CEO of BIGtoken following tenure on SRAX’s board of directors BIGtoken spinoff allows SRAX to focus on rapid growth of Sequire platform SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, recently announced that BIGtoken, its proprietary platform that empowers Internet users to control and profit from their data, will become a separate publicly-traded company with Malcolm CasSelle as CEO.…

MondayOct 12, 2020 11:39 am

Sugarmade (SGMD) Numbers In Line with Cannabis Industry Increasing Projections

Projections for U.S. retail sales of medical, recreational cannabis on pace to reach $15 billion by end of 2020 SGMD seeing consistent growth in numbers, supporting expert predictions CEO reports “increase in gross margins while demonstrating another breakout month-over-month performance on both the top and bottom line” Even with the global COVID-19 pandemic causing a speed bump, projections for the retail sales of medical and recreational cannabis in the United states are on pace to reach $15 billion by the end of 2020 (https://ibn.fm/tqh6O). Those numbers, which are an increase of approximately 40% over 2019 sales figures, may not surprise Sugarmade…

MondayOct 12, 2020 11:01 am

Pressure BioSciences (PBIO) Achieves Critical Milestone in Commercial Rollout of Revolutionary Nanoemulsification System

Pressure BioSciences has been making a name for itself as a leader in the development and sale of proprietary intense-pressure delivery systems to the worldwide life sciences field PBIO is developing a novel high pressure platform called Ultra-Shear Technology (“UST”) that processes oil-based solutions into water-soluble nanoemulsions that will allow the molecules inside the oil (e.g., CBD, Vitamins) to be more readily absorbed by human biology Development of th proprietary new instrument - the BaroShear K45-has been proceeding well since the Company received orders for all of its planned initial build of 12 units Pressure BioSciences reported achieving a critical…

MondayOct 12, 2020 10:50 am

QualityStocksNewsBreaks – Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) Enters Definitive Agreements with New Cornerstone Shareholders

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) today announced its entry into definitive agreements ("Definitive Agreements") with certain Barrick Gold Corporation subsidiaries and Augusta Investments Inc. in connection with the previously announced transaction pursuant to which Bullfrog will acquire rights to 1500 acres adjoining the company's Bullfrog Gold Deposit from Barrick, and Augusta and certain individuals identified by Augusta will concurrently complete a C$22 million investment in Bullfrog (the "Transaction"). "We are delighted to announce the signing of the Definitive Agreements and are encouraged by the positive market reaction to the announcement of the binding term sheet in…

MondayOct 12, 2020 9:48 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights New Glioblastoma-Focused Segment Airing on Lifetime TV

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today highlighted a new segment from The Balancing Act titled, "Behind the Mystery," which will air on Lifetime TV and focus on glioblastoma. The segment, live this morning, follows the unique story of a glioblastoma patient and clinical insights regarding the rare and difficult-to-treat disease from Dr. Sigmund Hsu, a member of CNS Pharmaceuticals’ Scientific Advisory Board. In addition, a re-airing of the segment is planned for October 23, 2020. "It is encouraging to…

Site Search

Company Search